STAT3阻塞通过巨驱动的炎症改善LPS诱导的损伤
Song-Hee Lee1,2, Kyu Hong Kim1, Seong Min Lee1
1Department of Biomedical Sciences, Seoul National University, Seoul, Republic of Korea.
Cell communication and signaling : CCS
|October 4, 2024
概括
阻断STAT3可以减少脏炎症和纤维化. 抑制STAT3使巨细胞群正常化,改善急性损伤和慢性病模型中的功能.
科学领域:
- 免疫学 免疫学 免疫学
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
背景情况:
- 信号转换器和转录3激活器 (STAT3) 在损伤中影响免疫反应和巨细胞表型.
- 在急性损伤 (AKI) 发病,巨细胞迁移和慢性病 (CKD) 纤维化中STAT3的特定作用仍然不完全理解.
研究的目的:
- 在LPS诱导的AKI和CKD模型中研究STAT3抑制的治疗潜力.
- 阐明STAT3阻断对巨细胞群和功能影响的免疫机制.
主要方法:
- 施用Stattic (一种JAK2/STAT3抑制剂) 给患有LPS诱导的AKI和CKD的小鼠.
- 对巨细胞表型,功能参数 (BUN,肌素),管状损伤得分和炎症标志物的分析 (NGAL,F4/80,p-STAT3).
- 转录组分析以确定受影响的信号通路,并确认抗炎和抗纤维效应.
主要成果:
- 在AKI和CKD模型中,STAT3抑制减少了损伤,炎症和纤维化.
- 静态治疗调节了巨细胞亚种群,增加了CD11b低F4/80高 (M2类) 种群.
- 转录组分析显示了JAK-STAT,TLR和TNF信号通路的调节,PI3K-AKT和JAK-STAT被确定为潜在的Stattic目标.
结论:
- STAT3阻断在减轻脏炎症和纤维化方面显示出显著的治疗效果.
- 与STAT3相关的巨细胞驱动的炎症在损伤中起着关键作用,其阻塞提供了一个有前途的治疗策略.
相关概念视频
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...


